Hizentra

(human normal immunoglobulin (SCIg))

Uses, side effects, dosage information & price range

CSL Behring GmbH

About this medicine

Replacement therapy in adults, children and adolescents (0-18 years) in: - Primary immunodeficiency syndromes with impaired antibody production (see section 4.4). - Secondary immunodeficiencies (SID) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (PSAF)* or serum IgG level of <4 g/l. *PSAF = failure to mount at least a 2-fold rise in IgG antibody titre to pneumococcal polysaccharide and polypeptide antigen vaccines. Immunomodulatory therapy in adults, children and adolescents (0-18 years): - Hizentra is indicated for the treatment of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) as maintenance therapy after stabilization with IVIg.  

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

BeyfortusComposition: nirsevimabSanofi Winthrop Industrie

Price on RequestView Details →

EnflonsiaComposition: clesrovimabMerck Sharp Dohme Limited

Price on RequestView Details →

KavigaleComposition: sipavibartAstraZeneca AB

Price on RequestView Details →

XevudyComposition: sotrovimabGlaxoSmithKline Trading Services Limited

Price on RequestView Details →

HyQviaComposition: human normal immunoglobulinBaxalta Innovations GmbH

Price on RequestView Details →

Key Information

Salt / Composition

human normal immunoglobulin (SCIg)